Effect Study of SMART Treatment for Youth
UTVID
A Randomized Controlled Evaluation of Sensory Motor Arousal Regulation Treatment (SMART) for Youth With Developmental Trauma and Self-regulation Difficulties
1 other identifier
interventional
120
1 country
4
Brief Summary
The goal of this clinical trial is to learn if Sensory motor arousal regulation treatment (SMART) works better than treatment as usual (TAU) to treat youth 7-17 years with complex trauma histories and self-regulation difficulties. The study also will investigate which patients will benefit more from SMART (treatment effect heterogeneity) and whether therapeutic alliance mediates effect. The main hypotheses the trial aims to answer are:
- 1.Main effects: The SMART model approach will be more effective than ordinary treatment (control condition), in terms of improvement from therapy starts to 6 and 12 months follow up, for:
- 2.Regulatory capacities of emotions and bodily states, attention and behavior, and self and social relations
- 3.Trauma symptoms of re-experiencing, avoidance/ numbness and hyperarousal and sense of threat (core PTSD symptoms) and disturbances in self-organization (affect, self-concept; relations - core complex PTSD symptoms)
- 4.Internalizing symptoms (somatic complaints, anxiety symptoms and depression symptom severity) and Externalizing symptoms (conduct problems, aggression, inattention, and social problem severity)
- 5.Psychosocial strengths - prosocial behavior, subjective well-being and impairment in peer relationships, family relationships, and academic/school functioning
- 6.Exploration of mediation: When comparing SMART and ordinary treatment (TAU), (i) therapeutic alliance is higher in SMART, and (ii) a better treatment effect in SMART is partially mediated by therapeutic alliance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2025
CompletedStudy Start
First participant enrolled
September 25, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
October 1, 2025
September 1, 2025
2.3 years
September 10, 2025
September 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-regulation difficulties
Domains B, C and D on the Developmental trauma disorder semistructured interview (DTD-SI). Scores on DTD-SI range from 0-15, where higher scores mean more self-regulation difficulties (and worse outcome).
The outcome is assessed by trained study personell at Baseline (Day 1) and at follow up 6 months and 12 months after Baseline.
Secondary Outcomes (4)
International Trauma Questionnaire (ITQ)
The outcome is assessed by trained study personell at Baseline (Day 1) and at follow up 6 months and 12 months after Baseline.
Strenght and Difficulties Questionnaire (SDQ)
Assessed at baseline and 6 and 12 months follow up
Child Behavior Checklist (CBCL/6-18)/ Youth self-report (YRS) from ASEBA
Assessed at baseline and at 6 and 12 months follow up
Child outcome rating scale (CORS)
Assessed at baseline and at 6 and 12 months follow up
Other Outcomes (2)
Therapeutic alliance scale for children - revised (TASC-R)
Measured after the 3rd and the 7th psychotherapy treatment session, that is, 3 and 7 weeks after Baseline - since participants will receive one psychotherapy treatment session per week.
Session rating scale for children (CSRS)
Measured after the 3rd and the 7th psychotherapy treatment session, that is, 3 and 7 weeks after Baseline - since participants will receive one psychotherapy treatment session per week.
Study Arms (2)
Sensory motor arousal regulation treatment (SMART)
EXPERIMENTALTreatment using SMART rooms and associated SMART techniques
Treatment as usual (TAU)
ACTIVE COMPARATORBest practice ordinary treatment without using SMART approaches
Interventions
Psychological treatment using SMART room and associated techniques
Eligibility Criteria
You may qualify if:
- The presence of developmental trauma history (domain A)
- One symptom in each of the domains B-D
- At least four symptoms (of a maximum 15) in domains B-D considered together
- Domains A to D above refers to the following:
- Domain A. Lifetime contemporaneous exposure to developmental trauma, defined as either (i) Interpersonal victimization: physical or sexual abuse or assault, domestic/intimate partner violence, bullying, harassment, exploitation, trafficking, hate crimes, or racial/ethnic/identity trauma, or (ii) Primary caregiving system attachment disruption: caregiver change or prolonged separation, gross neglect (physical, medical, emotional), psychological maltreatment (emotional abuse, emotional neglect, parental hostility or over-controlling), caregiver impairment due to mental illness or substance abuse, or chronic medical condition (by child or caregiver)
- Domain B. Affective and somatic dysregulation: (i) Emotion dysregulation, (ii) Somatic dysregulation, (iii) Impaired awareness or dissociation of emotions and body, (iv) Impaired capacity to describe emotions or bodily states
- Domain C. Attentional and behavioral dysregulation: (i) Threat-related rumination, (ii) Impaired capacity for self protection, (iii) Maladaptive self-soothing, (iv) Habitual or reactive self-harm, (v) Inability to initiate or sustain goal-directed behavior
- Domain D. Self and relational dysregulation: (i) Persistent extreme negative self-perception, (ii) attachment insecurity and disorganization, (iii) Extreme persistent distrust, defiance or lack of reciprocity in close relationships, (iv) Reactive physical or verbal aggression, (v) Psychological boundary deficits, (vi) Impaired capacity to regulate empathic arousal
You may not qualify if:
- Active psychosis
- Not fluent in Norwegian language
- Developmental challenges - IQ \< 70
- Has previously used SMART room
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Asker
Asker, Akershus, Norway
Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Ringerike Ål
Ål, Buskerud, Norway
Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Drammen
Drammen, Buskerud, Norway
Dpt of Child and Adolescent Mental Health (CAMH) Vestre Viken - Kongsberg
Kongsberg, Buskerud, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roar Fosse, Ph.D.
Vestre Viken Hospital Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2025
First Posted
October 1, 2025
Study Start
September 25, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share